These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3315441)

  • 1. Peritoneal membrane defence mechanism in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Contrib Nephrol; 1987; 57():69-78. PubMed ID: 3315441
    [No Abstract]   [Full Text] [Related]  

  • 2. Phagocytic defence against CAPD peritonitis. The bacterium, the phagocyte, and the doctor.
    Verbrugh HA; van Bronswijk H; van der Meulen J; Oe PL; Verhoef J
    Contrib Nephrol; 1987; 57():85-91. PubMed ID: 3677705
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Biomater Artif Cells Artif Organs; 1987; 15(1):151-9. PubMed ID: 3329538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of peritoneal infection by the natural defences of the peritoneal cavity.
    Guiberteau R; le Chapois D; Nony A; Talin d'Eyzac A
    Contrib Nephrol; 1987; 57():92-100. PubMed ID: 3677706
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of human peritoneal macrophages from continuous ambulatory peritoneal dialysis (CAPD) patients.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    FEMS Microbiol Immunol; 1989 Apr; 1(5):303-4. PubMed ID: 2631872
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of recurrent and resistant CAPD peritonitis by temporary withdrawal of peritoneal dialysis without removal of the catheter.
    Locatelli A; Quiroga MA; De Benedetti L; Gomez M; Barone R; Barron MC
    Adv Perit Dial; 1995; 11():176-8. PubMed ID: 8534698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Yewdall VM; Ogg CS; Cameron JS
    Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
    Lin CY; Huang TP
    Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?
    de Fijter CW; Verbrugh HA; Oe PL; Heezius EC; Verhoef J; Donker AJ
    Nephrol Dial Transplant; 1994; 9(2):156-62. PubMed ID: 8190329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial peritonitis in CAPD: pathogenesis, symptoms, therapy and progress.
    Augustin R; Kuhlmann U; Schmid E; Wisser H
    Contrib Nephrol; 1987; 57():10-22. PubMed ID: 3677682
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial peritonitis in continuous ambulatory peritoneal dialysis: effect on dialysis on host defense mechanisms.
    Findon G; Miller T
    Am J Kidney Dis; 1995 Nov; 26(5):765-73. PubMed ID: 7485129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis.
    Fieren MW; van den Bemd GJ; Bonta IL
    Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.
    Keane WF; Comty CM; Verbrugh HA; Peterson PK
    Kidney Int; 1984 Mar; 25(3):539-43. PubMed ID: 6376908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic patterns in CAPD patients with peritonitis.
    Lamperi S; Carozzi S
    Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis.
    Lamperi S; Carozzi S
    Nephron; 1986; 44(3):219-25. PubMed ID: 2946966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD).
    Lamperi S; Carozzi S
    Am J Kidney Dis; 1988 Mar; 11(3):225-30. PubMed ID: 3125740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
    de Fijter CW; Verbrugh HA; Heezius HC; van Bronswijk H; van der Meulen J; Oe PL; Donker AJ; Verhoef J
    Adv Perit Dial; 1989; 5():124-7. PubMed ID: 2577393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis.
    van Bronswijk H; Verbrugh HA; Heezius HC; van der Meulen J; Oe PL; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):368-73. PubMed ID: 3137037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.